RJT
MPT

Raymond James Trust’s Medical Properties Trust MPT Stock Holding History

Raymond James Trust’s Portfolio MPT Stock Details MPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$133K Sell
22,757
-4,288
-16% -$21.1K ﹤0.01% 1275
2024
Q2 		$117K Sell
27,045
-2,250
-8% -$10.8K ﹤0.01% 1222
2024
Q1 		$138K Sell
29,295
-2,865
-9% -$11K ﹤0.01% 1214
2023
Q4 		$158K Sell
32,160
-5,683
-15% -$27.8K ﹤0.01% 1162
2023
Q3 		$206K Sell
37,843
-3,846
-9% -$30.8K 0.01% 1072
2023
Q2 		$386K Buy
41,689
+468
+1% +$3.96K 0.01% 776
2023
Q1 		$339K Sell
41,221
-13,381
-25% -$148K 0.01% 809
2022
Q4 		$608K Buy
54,602
+1,772
+3% +$20.6K 0.02% 533
2022
Q3 		$626K Buy
52,830
+7,401
+16% +$112K 0.02% 504
2022
Q2 		$694K Buy
45,429
+7,680
+20% +$138K 0.02% 472
2022
Q1 		$798K Buy
37,749
+5,046
+15% +$109K 0.02% 480
2021
Q4 		$772K Buy
32,703
+2,861
+10% +$61.3K 0.02% 502
2021
Q3 		$599K Buy
29,842
+1,515
+5% +$31K 0.02% 558
2021
Q2 		$570K Buy
28,327
+693
+3% +$14.8K 0.02% 562
2021
Q1 		$588K Sell
27,634
-2,585
-9% -$55.6K 0.02% 527
2020
Q4 		$659K Buy
30,219
+9
+0% +$175 0.03% 453
2020
Q3 		$533K Sell
30,210
-5,093
-14% -$94.8K 0.02% 480
2020
Q2 		$664K Sell
35,303
-484
-1% -$8.57K 0.03% 388
2020
Q1 		$619K Sell
35,787
-11
-0% -$230 0.04% 358
2019
Q4 		$756K Buy
35,798
+1,275
+4% +$25.8K 0.04% 367
2019
Q3 		$675K Buy
34,523
+8,115
+31% +$149K 0.03% 382
2019
Q2 		$460K Buy
26,408
+4,866
+23% +$87.6K 0.03% 461
2019
Q1 		$399K Buy
21,542
+4,892
+29% +$87.2K 0.02% 492
2018
Q4 		$268K Buy
16,650
+238
+1% +$3.77K 0.02% 596
2018
Q3 		$244K Buy
16,412
+3,496
+27% +$51K 0.01% 721
2018
Q2 		$181K Buy
12,916
+1,083
+9% +$14.3K 0.01% 789
2018
Q1 		$154K Buy
11,833
+535
+5% +$6.85K 0.01% 686
2017
Q4 		$156K Sell
11,298
-435
-4% -$5.88K 0.01% 713
2017
Q3 		$154K Buy
11,733
+125
+1% +$1.61K 0.01% 700
2017
Q2 		$150K Sell
11,608
-310
-3% -$4.13K 0.01% 694
2017
Q1 		$154K Buy
+11,918
New +$152K 0.01% 674

Other funds holding MPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

Raymond James Trust's MPT Position: Q3 2024 in Review

Raymond James Trust reduced its Medical Properties Trust (MPT) stake by 16% in Q3 2024, selling an estimated $21.1K and leaving 22,757 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #1275.

Raymond James Trust first reported a position in MPT in Q1 2017 and has held it in 31 quarters since. The position peaked at $798K in Q1 2022. 506 funds tracked by Wall St. Rank hold MPT as of Q3 2024.

  • Raymond James Trust held 22,757 shares of Medical Properties Trust worth $133K as of Q3 2024.
  • Raymond James Trust sold 4,288 Medical Properties Trust shares in Q3 2024, an estimated $21.1K.
  • Medical Properties Trust made up ﹤0.01% of Raymond James Trust's portfolio in Q3 2024, its #1275 holding.
  • Raymond James Trust first reported a position in Medical Properties Trust in Q1 2017 and has held it in 31 quarters since.
  • Raymond James Trust's Medical Properties Trust position peaked at $798K in Q1 2022.
  • 506 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.